Skip to main content

Peer Review reports

From: No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

Original Submission
26 Sep 2009 Submitted Original manuscript
19 Jan 2010 Author responded Author comments - Annette Vangsted
9 Nov 2009 Reviewed Reviewer Report - Jose Agundez
11 Nov 2009 Reviewed Reviewer Report - Magnus Ingelman-Sundberg
Resubmission - Version 2
19 Jan 2010 Submitted Manuscript version 2
4 Feb 2010 Reviewed Reviewer Report - Jose Agundez
22 Mar 2010 Reviewed Reviewer Report - Magnus Ingelman-Sundberg
30 Apr 2010 Reviewed Reviewer Report - Kui Zhang
Resubmission - Version 3
Submitted Manuscript version 3
14 Jun 2010 Author responded Author comments - Annette Vangsted
Resubmission - Version 4
14 Jun 2010 Submitted Manuscript version 4
25 Jul 2010 Author responded Author comments - Annette Vangsted
25 Jun 2010 Reviewed Reviewer Report - Kui Zhang
Resubmission - Version 5
25 Jul 2010 Submitted Manuscript version 5
Publishing
4 Aug 2010 Editorially accepted
4 Aug 2010 Article published 10.1186/1471-2407-10-404

You can find further information about peer review here.

Back to article page